Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024Business Wire • 6 days ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on...
Share to Feed
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief...
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Zacks Research decreased their Q2 2024 earnings per share (EPS) estimates for shares of Bio-Rad Laboratories in a research report issued to...
In trading on Monday, shares of Bio-Rad Laboratories Inc (BIO) crossed below their 200 day moving average of 344.66, changing hands as low as 337.23 per share. Bio-Rad Laboratories Inc...
In this article, we will be taking a look at the 25 countries with highest malaria death rates. If you do not want to learn about the global malaria diagnostics market, head straight to the 5...
A month has gone by since the last earnings report for Perrigo (PRGO). Shares have added about 19.1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up...
Public Employees Retirement System of Ohio lowered its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO Free Report) by 9.7% during the third quarter, according to its most recent Form 13F...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new...
StockNews.com upgraded shares of Bio-Rad Laboratories (NYSE:BIO Free Report) from a hold rating to a buy rating in a research report report published on Friday. BIO has been the subject of...
O Shaughnessy Asset Management LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO Free Report) in the 3rd quarter, according to its most recent filing with the Securities...